Caption Management, LLC Amgen Inc Call Options Transaction History

Caption Management, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $3.09 Million - $3.37 Million	-10,000 Reduced 47.62%	11,000 $3.54 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $2.63 Million - $3.19 Million	10,000 Added 90.91%	21,000 $6.56 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $2.81 Million - $3.17 Million	11,000 New	11,000 $3.17 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $3.07 Million - $3.9 Million	13,400 Added 47.86%	41,400 $10.9 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $6.28 Million - $7.09 Million	28,000 New	28,000 $6.31 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $18.6 Million - $20.6 Million	85,000 New	85,000 $20.6 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $212,270 - $248,700	-1,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $233,580 - $259,140	1,000 New	1,000 $244,000
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $11.7 Million - $13 Million	-50,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $9.89 Million - $12.1 Million	50,000 New	50,000 $11.8 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.